← Back to Analyst Consensus 
PLX Buy
Protalix BioTherapeutics, Inc.
Current Price —
Implied Upside —
Analysts 5
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Next Earnings
Nov 16, 2026 (21 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Sep 9, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| Mar 19, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| Nov 21, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $12 | 44% |
| Feb 3, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $15 | 44% |
| Nov 14, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $10 | 44% |
| Oct 31, 2023 | HC Wainwright & Co. | maintain | Buy → Buy | $10 | 44% |
Price Target Trend
Apr 24, 2026 Oct 26, 2026
EPS Estimates
+1y —
0y —
0q —
+1q —
Cross-Platform Signals
No cross-platform signals in the last 90 days